ArticleJournal of clinical medicine2019

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study.

Evripidis Kaltsonoudis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.